Market Cap
Moderna, Inc. Market Capitalization:
$44.44 Billion
USD as of July 1, 2024
Moderna, Inc. Main Stock Listing
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
Novo Nordisk
|
$622.07 B |
Vertex Pharmaceuticals Incorporated
|
$121.36 B |
|
Regeneron Pharmaceuticals, Inc.
|
$115.11 B |
CSL Limited
|
$95.75 B |
| Marinomed Biotech AG | $75.67 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
Lilly
|
$808.65 B |
|
Novo Nordisk
|
$622.07 B |
|
UnitedHealth Group
|
$450.89 B |
|
Johnson & Johnson
|
$350.63 B |
|
Merck
|
$318.75 B |
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Company Description
Moderna, Inc. is a biotechnology company, specialized in vaccine technology based on messenger RNA. It is notably famous for producing one of the first vaccines against Covid-19, and it is also developing and patenting other vaccine candidates for seasonal flu, HIV, the Nipah virus, and a second COVID-19 vaccine.
Moderna, Inc. Categories
United States
languages
Healthcare
languages
Biotechnology
United States Healthcare
United States Biotechnology
Stocks & Indices
Moderna, Inc. has the following listings and related stock indices.
Stock: NASDAQ: MRNA
Stock: BMV: MRNA
Stock: Bovespa: M1RN34
Stock: FSX: 0QF
What is a company's market capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.